RARE
Ultragenyx Pharmaceutical Inc.
Latest News for RARE
In a report released yesterday, Anupam Rama from J.P. Morgan maintained a Buy rating on Ultragenyx Pharmaceutical, with a price target of $72.00. T......
Ultragenyx Pharmaceutical, Inc. (($RARE)) has held its Q1 earnings call. Read on for the main highlights of the call. Ultragenyx Pharmaceutical’s l......
Ultragenyx Pharmaceutical ( ($RARE) ) has issued an announcement. At its Annual Meeting of Stockholders held on May 14, 2026, Ultragenyx Pharmaceut......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kodiak Sciences (KOD), IN8bio (INAB) and Ultragenyx ......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kodiak Sciences (KOD), IN8bio (INAB) and Ultragenyx ......
In a report released today, Eliana Merle from Barclays maintained a Buy rating on Ultragenyx Pharmaceutical, with a price target of $43.00. Merle c......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alphatec Holdings (ATEC) and Ultragenyx Pharmaceutic......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RARE | $23.14 | -1.1% | 1.22M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ultragenyx Pharmaceutical Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW